References
- Lloyd-Jones DM, Leip EP, Larson MG, et al. Prediction of lifetime risk of CVD by risk factor burden at age 50. Circulation 2006;113:791–8
- Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013 Nov 7. pii: S0735–1097(13)06028–2. Epub ahead of print
- Ridker P, Cook N. Statins: new American guidelines for prevention of cardiovascular disease. Lancet 2013;382:1762–5
- Hodis H, Collins P, Mack WJ, Schierbeck LL. The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspective. Climacteric 2012;15:217–22
- Fenton A, Panay N. Statins in women for primary prevention – is there evidence to back up their use?Climacteric 2010;13:403–4
- Mora S, Glynn R, Hsia J, MacFadyen J, Genest J, Ridker P. Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia. Results from the Justification for the use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials. Circulation 2010;121:1069–77
- Taylor F, Huffman MD, Macedo AF, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013, Jan 31;1:CD004816
- Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 2010;375:735–42
- Harper CR, Jacobson TA. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis. Curr Opin Lipidol 2007;18:401–8
- Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative Randomized trials. JAMA 2013;310:1353–68
- Schierbeck LL, Rejnmark L, Landbo Tofteng C, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ 2012; 345:e6409